NCT00257478

Brief Summary

A study for the treatment of hormone refractory prostate cancer (HRPC) in patients previously treated with chemotherapy.

Trial Health

85
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Geographic Reach
3 countries

9 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 22, 2005

Completed
1 day until next milestone

First Posted

Study publicly available on registry

November 23, 2005

Completed
1.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2007

Completed
Last Updated

June 7, 2012

Status Verified

June 1, 2012

First QC Date

November 22, 2005

Last Update Submit

June 6, 2012

Conditions

Prostate CancerCancer of ProstateProstatic CancerCancer of the Prostate

Keywords

Treatment EfficacyTreatment EffectivenessDisease ManagementTreatmentSafety

Interventions

YM155DRUG

Eligibility Criteria

Age18 Years+
Sexmale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Histologically or cytologically confirmed prostate cancer.
  • Prior chemotherapy regimen for prostate cancer

You may not qualify if:

  • History of other malignancy in the last 5 years
  • Major surgery within the past 21 days

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (9)

Unknown Facility

Tuscon, Arizona, 85724, United States

Location

Unknown Facility

Los Angeles, California, 90033, United States

Location

Unknown Facility

Coeur d'Alene, Idaho, 83814, United States

Location

Unknown Facility

New York, New York, 10016, United States

Location

Unknown Facility

The Bronx, New York, 10461, United States

Location

Unknown Facility

Philadelphia, Pennsylvania, 19111, United States

Location

Unknown Facility

San Antonio, Texas, 78229, United States

Location

Unknown Facility

Amsterdam, Netherlands

Location

Unknown Facility

Sutton, Surry, SM2 5Pt, United Kingdom

Location

MeSH Terms

Conditions

Prostatic Neoplasms

Interventions

sepantronium

Condition Hierarchy (Ancestors)

Genital Neoplasms, MaleUrogenital NeoplasmsNeoplasms by SiteNeoplasmsGenital Diseases, MaleGenital DiseasesUrogenital DiseasesProstatic DiseasesMale Urogenital Diseases

Study Officials

  • D. Buell, MD

    Astellas Pharma US, Inc.

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY

Study Record Dates

First Submitted

November 22, 2005

First Posted

November 23, 2005

Study Completion

March 1, 2007

Last Updated

June 7, 2012

Record last verified: 2012-06

Locations

NL(1)US(7)GB(1)